Literature DB >> 8891088

Major depressive disorder is associated with elevated monocyte counts.

A Seidel1, V Arolt, M Hunstiger, L Rink, A Behnisch, H Kirchner.   

Abstract

One of the most consistently reported findings in depression has been leucocytosis. In 33 in-patients with major depressive disorder, we assessed white blood cell count (WBC) and lymphocyte subsets four times over a period of 6 weeks. The control group consisted of 44 healthy subjects. Shortly after admission, we detected significant increases in the numbers of leucocytes, granulocytes, platelets and monocytes in the depressed patients. Patients who recovered well during hospitalization showed a decrease in monocyte counts, whereas those with slower clinical improvement had significantly higher monocyte counts than the control group. This longitudinal study demonstrates that monocytes may play a role in the acute phase of depression and could provide an explanation for immunological dysfunction in depressive states.

Entities:  

Mesh:

Year:  1996        PMID: 8891088     DOI: 10.1111/j.1600-0447.1996.tb09849.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  27 in total

1.  Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflammatory response.

Authors:  M Maes; R Verkerk; E Vandoolaeghe; F Van Hunsel; H Neels; A Wauters; P Demedts; S Scharpé
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1997       Impact factor: 5.270

2.  Methylomic profiles reveal sex-specific differences in leukocyte composition associated with post-traumatic stress disorder.

Authors:  Grace S Kim; Alicia K Smith; Fei Xue; Vasiliki Michopoulos; Adriana Lori; Don L Armstrong; Allison E Aiello; Karestan C Koenen; Sandro Galea; Derek E Wildman; Monica Uddin
Journal:  Brain Behav Immun       Date:  2019-06-19       Impact factor: 7.217

3.  Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?

Authors:  Mandy Busse; Stefan Busse; Aye Mu Myint; Tomasz Gos; Henrik Dobrowolny; Ulf J Müller; Bernhard Bogerts; Hans-Gert Bernstein; Johann Steiner
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-11-20       Impact factor: 5.270

Review 4.  An Act of Balance Between Adaptive and Maladaptive Immunity in Depression: a Role for T Lymphocytes.

Authors:  Catherine Toben; Bernhard T Baune
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-02       Impact factor: 4.147

Review 5.  Inflammatory biomarkers and depression.

Authors:  Norbert Müller; Aye-Mu Myint; Markus J Schwarz
Journal:  Neurotox Res       Date:  2010-07-24       Impact factor: 3.911

6.  Clozapine protects dopaminergic neurons from inflammation-induced damage by inhibiting microglial overactivation.

Authors:  Xiaoming Hu; Hui Zhou; Dan Zhang; Sufen Yang; Li Qian; Hung-Ming Wu; Po-See Chen; Belinda Wilson; Hui-Ming Gao; Ru-band Lu; Jau-Shyong Hong
Journal:  J Neuroimmune Pharmacol       Date:  2011-08-26       Impact factor: 4.147

7.  Imipramine attenuates neuroinflammatory signaling and reverses stress-induced social avoidance.

Authors:  Karol Ramirez; Daniel T Shea; Daniel B McKim; Brenda F Reader; John F Sheridan
Journal:  Brain Behav Immun       Date:  2015-02-18       Impact factor: 7.217

8.  [Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy].

Authors:  C Laske; T Leyhe; G Buchkremer; H Wormstall
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

Review 9.  [Immunological aspects of depressive disorders].

Authors:  N Müller; M J Schwarz
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

10.  Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response.

Authors:  M-L Wong; C Dong; J Maestre-Mesa; J Licinio
Journal:  Mol Psychiatry       Date:  2008-05-27       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.